Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev ET
ISSN: 1312-773X (Online)
Issue: 2017, vol. 23, issue 1
Subject Area: Medicine
Pages: 1453-1455
DOI: 10.5272/jimab.2017231.1453
Published online: 07 February 2017

J of IMAB 2017 Jan-Mar;23(1):1453-1455
IMPORTANCE OF THE STABILITY OF LEGAL SYSTEM FOR THE SUCCESSFUL MANAGING OF A STRUCTURE OF MEDICAL SERVICES COMPANIES
Mariela Deliverska1Corresponding Autor, Ivan Doshkov2
1) Department of Medical Ethics and Law , Faculty of Public Health, Medical University - Sofia, Bulgaria
2) Department of health policy and management, Faculty of Public Health, Medical University - Sofia, Bulgaria.

ABSTRACT:
The process of introduction into our national legislation of norms of the European union legislation has a direct impact on the process of realization of major activities in all spheres of the public life and the activities related to medical services are not an exception.
The management of activities, connected to provision of medical services, requires attention to be paid not only to the competitive environment, but also to the normative requirements, regulating the access of the citizens to medical aid.
When talking about healthcare and healthcare market, it should be noted that good healthcare is possible only where there is good civil society and strong traditions in the field of social insurance.
The new requirements introduced in the way of functioning of the healthcare system aim to provide improved human health, however simultaneously the adaptation of the system to the new legally regulated requirements should be implemented in a way, which guarantees fast and easy access to healthcare services for all patients.

Key words: Healthcare, management, medical services, regulation,

- Download FULL TEXT /PDF 489 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Deliverska M, Doshkov I. Importance of the stability of legal system for the successful managing of a structure of medical services companies. J of IMAB. 2017 Jan-Mar;23(1):1453-1455. DOI: 10.5272/jimab.2017231.1453.

Correspondence to: Assoc. prof. Mariela Deliverska, LLM, PhD, DMSc, Department of Medical Ethics and Law, Faculty of Public Health, Medical University – Sofia; 8, Bialo more str., 1527 Sofia, Bulgaria; E-mail: mdeliverska@yahoo.com

REFERENCES:
1. European Commission. Patients’ rights in cross-border healthcare in European Union. Eurobarometer Special Report. May 2015. [CrossRef]
2. Council of Ministers of the Republic of Bulgaria. Regulation on the provision of the right of access to medical aid. Official Gazette. issue 45, 2 June 2006.
3. Deliversky J. Opportunities for limitation of corruption practices in the healthcare sector,  Varna Medical Forum. 2016; 5(2):221-225 [in Bulgarian]
4. Deliversky J. The pricing of clinical pathways as a precondition for the creation of corrupt practices at central level in healthcare. Varna Medical Forum. 2016; 5(2):217-220 [in Bulgarian]

Received: 03 November 2016
Published online: 07 February 2017

back to Online Journal